Anchor Capital Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-8,160
| Closed | -$944K | – | 285 |
|
|
2018
Q2 | $944K | Sell |
8,160
-1,359
| -14% | -$157K | 0.03% | 185 |
|
|
2018
Q1 | $940K | Sell |
9,519
-1,060
| -10% | -$105K | 0.03% | 202 |
|
|
2017
Q4 | $1.11M | Sell |
10,579
-339
| -3% | -$35.5K | 0.04% | 167 |
|
|
2017
Q3 | $1.23M | Sell |
10,918
-9,815
| -47% | -$1.11M | 0.04% | 155 |
|
|
2017
Q2 | $2.32M | Buy |
20,733
+77
| +0.4% | +$8.63K | 0.08% | 114 |
|
|
2017
Q1 | $2.41M | Buy |
20,656
+4,596
| +29% | +$536K | 0.08% | 116 |
|
|
2016
Q4 | $1.69M | Buy |
16,060
+499
| +3% | +$52.5K | 0.06% | 135 |
|
|
2016
Q3 | $1.72M | Buy |
15,561
+4,674
| +43% | +$517K | 0.06% | 135 |
|
|
2016
Q2 | $1.59M | Sell |
10,887
-260
| -2% | -$37.9K | 0.04% | 137 |
|
|
2016
Q1 | $1.6M | Buy |
+11,147
| New | +$1.6M | 0.04% | 147 |
|